Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trace amine-associated receptor 9 (TAAR9) is a rhodopsin-like G protein-coupled receptor with seven transmembrane domains, primarily known for detecting trace amines and volatile amine compounds in the olfactory system[1][2][4][7]. TAAR9 mediates signal transduction through G proteins, integrating chemical cues that may influence behavior and physiological responses such as lipid metabolism (e.g., affecting low-density lipoprotein cholesterol)[1]. Its endogenous ligands include polyamines and certain monoamines, and its activity involves complex ligand entry and binding mechanisms, including multiple entry tunnels and pockets within the receptor structure[2]. TAAR9, along with related TAAR family members, is being investigated as a potential therapeutic target for metabolic and inflammatory disorders, though clinical data are currently limited[7]. \n\nIf further granularity is needed for disease or drug information, continued research in the TAAR9 field is warranted due to currently limited ligand and expression profiling.
Agonists activate TAAR9 via binding to orthosteric and vestibular pockets, resulting in intracellular signaling through heterotrimeric G proteins typical of GPCRs\nAntagonists inhibit receptor activation, potentially interfering with physiological responses
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trace amine-associated receptor 9 (TAAR9).